Skip to content

Clinical trials

Phase 3 Heart Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Phase 3 Country / region: Netherlands Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20082
20093
20101
20112
20131
20181
20192
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated4
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Eidos Therapeutics, a BridgeBio company2
GlaxoSmithKline2
Sanofi2
Alexion Pharmaceuticals, Inc.1
Amarin Pharma Inc.1
AstraZeneca1
Bayer1
CSL Behring1
Erasmus Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases18
Cardiovascular Diseases8
Acute Coronary Syndrome5
Coronary Artery Disease5
Atherosclerosis4
Coronary Disease4
Stroke4
Peripheral Arterial Disease3
Renal Insufficiency, Chronic3
Vascular Diseases3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.